These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5871028)

  • 1. [Influence of the inhibition of monoamine oxidase on daily oscillation of the serotonin content of the brain].
    Montanaro N; Casoli R; Babbini M
    Arch Ital Sci Farmacol; 1965; 15(1):84-6. PubMed ID: 5871028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of administration of phenelzine, 5-hydroxytryptophan and their combination, on daily oscillation of the concentration of serotonin in the brain of the albino rat].
    Montanaro N; Graziani G
    Boll Soc Ital Biol Sper; 1967 Jan; 43(1):42-5. PubMed ID: 5298963
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of adepren on the cerebral concentration of serotonin].
    Tiutiulkova N; Gorancheva Iu
    Eksp Med Morfol; 1978; 17(2):83-5. PubMed ID: 658004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythm in the serotonin content of the rat pineal gland: regulating factors.
    Snyder SH; Axelrod J; Zweig M
    J Pharmacol Exp Ther; 1967 Nov; 158(2):206-13. PubMed ID: 4383637
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of the chemical structure of monoamine oxidase inhibitors for their effect on the gamma-aminobutyric acid content of the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1967; 18(5):617-24. PubMed ID: 5589667
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of monoamine content by decaborane after monoamine oxidase inhibition by iproniazid. SAM-TR-67-72.
    Merritt JH; Sulkowski TS
    Tech Rep SAM-TR; 1967 Jul; ():1-6. PubMed ID: 5301200
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of lipid peroxidation by monoamine oxidase enzyme inhibitors.
    Szökö E; Báthory G; Magyar K
    Acta Physiol Hung; 1990; 75 Suppl():269-70. PubMed ID: 2115231
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with pargyline.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1971 Aug; 42(4):646P. PubMed ID: 4256025
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo effects of isatin on certain enzymes, lipids & serotonergic system of rat brain.
    Kumar R; Bansal RC; Mahmood A
    Indian J Med Res; 1994 Nov; 100():246-50. PubMed ID: 7829161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamines and manic-depressive syndromes].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(2):487-98. PubMed ID: 4873952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of diethyldithiocarbamate on the monoamine oxidase activity and catecholamine and serotonin content in the tissues of guinea pigs administered ascorbic acid].
    Lokoshko EA
    Ukr Biokhim Zh; 1973; 45(6):698-701. PubMed ID: 4791112
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 19. The possibility of serotonin syndrome brought about by the use of metronidazole.
    Karamanakos PN
    Minerva Anestesiol; 2008 Nov; 74(11):679. PubMed ID: 18971895
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.